Results
1 -
10 of
24
(Click
here to explore results)
- Drug Transporters: Volume 1: Role and Importance in ADME and Drug Development, Chapter 1 Membrane Transporters: Fundamentals, Function and Their Role in ADME. John Keogh, Bruno Hagenbuch, Caroline Rynn, Bruno Stieger, Glynis Nicholls
, 2016
, Volume 1
, Pages 1-56
- The Medicinal Chemist's Guide to Solving ADMET Challenges, CHAPTER 8 Bile Salt Export Pump (BSEP) Inhibition. Alexander Treiber, Martin H. Bolli
, 2021
, Pages 160-172
- Orphan Drugs and Rare Diseases, Chapter 13 Treatments for Pulmonary Arterial Hypertension. Michael J. Palmer
, 2014
, Pages 369-397
- Drug Transporters: Volume 1: Role and Importance in ADME and Drug Development, Chapter 10 Transporter Drug–Drug Interactions: A Pharmaceutical Industry Perspective. Silke Simon, Mohammed Ullah, Robert van Waterschoot, Dietmar Schwab, Susan Grange, Caroline A. Lee, Christoph Funk
, 2016
, Volume 1
, Pages 361-417
- Designing Multi-Target Drugs, Chapter 19 Designing Drugs with Dual Activity: Novel Dual Angiotensin II and Endothelin Receptor Antagonists. Natesan Murugesan
, 2012
, Pages 316-334
- New Horizons in Predictive Toxicology: Current Status and Application, Chapter 22 Impact of Drug Transporters in the Pharmacological and Adverse Reactions of Drugs. Hiroyuki Kusuhara, Kazuya Maeda, Yuichi Sugiyama
, 2012
, Pages 563-598
- The Medicinal Chemist's Guide to Solving ADMET Challenges, Subject Index
, 2021
, Pages 493-517
- Environmental Cardiology: Pollution and Heart Disease, Chapter 4 Hypertension and Vascular Toxicity of PM. Z. Ying, S. Rajagopalan
, 2011
, Pages 121-142
- Perfluoroalkyl Substances: Synthesis, Applications, Challenges and Regulations, CHAPTER 10 Perfluoroalkylated Biomolecules for Medicinal Chemistry and Biological Studies. T. Brigaud, B. Crousse, T. Lequeux
, 2022
, Pages 459-476
- Macrocycles in Drug Discovery, CHAPTER 8 Macrocyclic Inhibitors of GPCR's, Integrins and Protein–Protein Interactions. Philipp Ermert, Kerstin Moehle, Daniel Obrecht
, 2015
, Pages 283-338